Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Journal of Infection Year : 2012

Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection.

Abstract

n.a

Domains

Infectious diseases
Embargoed file
Embargoed file
Ne sera jamais visible

Tristan Ferry  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00734708

Submitted on : Monday, September 24, 2012-2:18:25 PM

Last modification on : Tuesday, January 21, 2020-2:52:29 PM

Long-term archiving on: Friday, December 16, 2016-3:43:31 PM

Embargoed file
Please log in to request access to the document

Dates and versions

inserm-00734708 , version 1 (24-09-2012)

Identifiers

Cite

Tristan Ferry, Agathe Sénéchal, Marie-Claude Gagnieu, André Boibieux, Frédéric Laurent, et al.. Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection.: Prolonged high-dose ertapenem in BJI. Journal of Infection, 2012, 65 (6), pp.579-82. ⟨10.1016/j.jinf.2012.09.004⟩. ⟨inserm-00734708⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM HCL UNIV-LYON1 UDL
88 View
3 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More